Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Dornase Alfa (R05Cb13) Within The Framework Of A So-Called Open-House Model.

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  MT Ref Id - 99608112

  Document Type - Tender Notices

Description - Description: Conclusion of non-exclusive discount agreements in accordance with Sections 130a Paragraph 8/130c Paragraph 1 SGB V for medicinal products containing the active ingredient dornase alfa (R05CB13) within the period from February 1, 2025 to January 31, 2027 with the possibility of concluding the contract at any time (open-house model). In the open house procedure, medicinal products in accordance with the BfArM list in accordance with Section 35 Paragraph 5a SGB V (medicines for children) are excluded.local title:: Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Dornase alfa (R05CB13) im Rahmen eines sogenannt

Mt Ref Id - 99608112

Deadline - Nov 30, 2026